Marketing-authorisation holder · Canada
Jamp Pharma Corporation
1,019 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 1,019
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A.S.A. 325 MG TABLET325 mg · Tablet | Acetylsalicylic acid | Canada | Not marketed | 2003 |
| ABIRATERONE500 mg · Tablet | Abiraterone | Canada | Not marketed | 2022 |
| ABIRATERONE250 mg · Tablet | Abiraterone | Canada | Authorised | |
| ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE TABLETS300 mg + 15 mg + 8 mg · Tablet | Paracetamol, Caffeine, Codeine | Canada | Not marketed | 2004 |
| ACETAMINOPHEN ELIXIR WITH 8MG CODEINE PHOSPHATE SYRUP160 mg / 5 ml + 8 mg / 5 ml · Elixir | Paracetamol, Codeine | Canada | Authorised | |
| ACETAMINOPHEN PEDIATRIC DROPS 80 MG/ML USP80 mg / ml · Drops | Paracetamol | Canada | Not marketed | 2006 |
| ACETAMINOPHEN RELIEF REGULAR STRENGTH325 mg + 65 mg · Tablet | Paracetamol, Caffeine | Canada | Authorised | |
| ACETAMINOPHEN TABLETS USP SOFT CHEWS 160MG160 mg · Tablet (Chewable) | Paracetamol | Canada | Not marketed | 2003 |
| ACETAMINOPHEN ULTRA RELIEF EXTRA STRENGTH500 mg + 65 mg · Tablet | Paracetamol, Caffeine | Canada | Authorised | |
| ACTIVATED CHARCOAL225 mg · Capsule | Charcoal activated | Canada | Marketed | 2019 |
| ALLERGY AND SINUS RELIEF EXTRA STRENGTH500 mg + 4 mg + 10 mg · Tablet | Paracetamol, Chlorpheniramine, Phenylephrine | Canada | Authorised | |
| AMIKACIN SULFATE INJECTION250 mg / ml · Solution | Amikacin | Canada | Marketed | 2023 |
| AMIODARONE HYDROCHLORIDE FOR INJECTION50 mg / ml · Solution | Amiodarone | Canada | Not marketed | 2022 |
| AMLODIPINE10 mg · Tablet | Amlodipine | Canada | Marketed | 2014 |
| AMLODIPINE2.5 mg · Tablet | Amlodipine | Canada | Marketed | 2020 |
| AMLODIPINE5 mg · Tablet | Amlodipine | Canada | Marketed | 2014 |
| ANTACID PLUS EXTRA STRENGTH306 mg / 5 ml + 400 mg / 5 ml + 40 mg / 5 ml · Solution | Aluminum hydroxide, Hydroxide, Dimethicone | Canada | Not marketed | 2006 |
| ANTACID REGULAR WITH ANTI-GAS200 mg / 5 ml + 200 mg / 5 ml + 20 mg / 5 ml · Liquid | Aluminum hydroxide, Hydroxide, Dimethicone | Canada | Not marketed | 2006 |
| ANTACID WITH ALUMINA, MAGNESIA PLUS SIMETHICONE ORAL SUSPENSION USP174 mg / 5 ml + 200 mg / 5 ml + 25 mg / 5 ml · Suspension | Aluminum hydroxide, Hydroxide, Dimethicone | Canada | Not marketed | 1995 |
| ANTIBIOTIC OINTMENT500 unit / g + 10000 unit / g · Ointment | Bacitracin, Polymyxin b | Canada | Not marketed | 2006 |
| AUDRINA 2120 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 2023 |
| AUDRINA 2820 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 2023 |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canada | Not marketed | 2022 |
| AZITHROMYCIN FOR INJECTION500 mg / vial · Powder For Solution | Azithromycin | Canada | Marketed | 2022 |
| BACLOFEN INJECTION USP2 mg / ml · Solution | Baclofen | Canada | Marketed | 2025 |